Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 3
×
Carcinoma
×
130-nm albumin-bound paclitaxel
×
Clear all
Filters
3
NCT04222972
2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3
Terminated
223 enrolled
18 charts
NCT03976362
2026-02-25
KEYLYNK-008
Merck Sharp & Dohme LLC
Phase 3
Completed
851 enrolled
25 charts
NCT02915744
2023-04-14
ATTAIN
Nektar Therapeutics
Phase 3
Completed
178 enrolled
37 charts
NCT02367781
2021-08-09
IMpower130
Hoffmann-La Roche
Phase 3
Completed
723 enrolled
28 charts
1 FDA